Hyperandrogenemia and Altered Day-night LH Pulse Patterns
clinical trial
Press Enter · cited answer in seconds
0 sources
Summary
Hyperandrogenemia and Altered Day-night LH Pulse Patterns is a clinical trial[1].
Key Facts
- Hyperandrogenemia and Altered Day-night LH Pulse Patterns is in the country of United States[2].
- Hyperandrogenemia and Altered Day-night LH Pulse Patterns's instance of is recorded as clinical trial[3].
- Hyperandrogenemia and Altered Day-night LH Pulse Patterns's start time is recorded as +2016-07-31T00:00:00Z[4].
- Hyperandrogenemia and Altered Day-night LH Pulse Patterns's end time is recorded as +2025-04-30T00:00:00Z[5].
- Hyperandrogenemia and Altered Day-night LH Pulse Patterns's sponsor is recorded as University of Virginia[6].
- Hyperandrogenemia and Altered Day-night LH Pulse Patterns's main subject is recorded as polycystic ovary syndrome[7].
- Hyperandrogenemia and Altered Day-night LH Pulse Patterns's main subject is recorded as hyperandrogenism[8].
- Hyperandrogenemia and Altered Day-night LH Pulse Patterns's number of participants is recorded as {'unit': '1', 'amount': '+32'}[9].
- Hyperandrogenemia and Altered Day-night LH Pulse Patterns's title is recorded as Study to Evaluate if Androgen-receptor Blockade (Spironolactone) Improves Progesterone-suppression of Wake Luteinizing Hormone Pulse Frequency in Pubertal Girls With Hyperandrogenism[10].
- Hyperandrogenemia and Altered Day-night LH Pulse Patterns's short name is recorded as CRM008[11].
- Hyperandrogenemia and Altered Day-night LH Pulse Patterns's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+10'}[12].
- Hyperandrogenemia and Altered Day-night LH Pulse Patterns's ClinicalTrials.gov ID is recorded as NCT03068910[13].
- Hyperandrogenemia and Altered Day-night LH Pulse Patterns's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+17'}[14].
- Hyperandrogenemia and Altered Day-night LH Pulse Patterns's research intervention is recorded as progesterone[15].
- Hyperandrogenemia and Altered Day-night LH Pulse Patterns's research intervention is recorded as Spironolactone[16].
- Hyperandrogenemia and Altered Day-night LH Pulse Patterns's clinical trial phase is recorded as phase I clinical trial[17].
- Hyperandrogenemia and Altered Day-night LH Pulse Patterns's research subject recruitment status is recorded as recruiting[18].
- Hyperandrogenemia and Altered Day-night LH Pulse Patterns's study type is recorded as interventional study[19].